Editing DNA For Fame and Fortune
An anonymous reader writes: The world of genome editing is booming, with several startups racing to develop new tools and therapies out of the DNA-hacking insights of several hotshot scientists. Venture capitalists are pouring big money into this so-called 'CRISPR craze,' which has attracted over $600 million in funding since the beginning of 2013. But major questions loom over who is the rightful owner of this technology, and the leading parties are battling for control of the key patents. Will this new crop of genome-editing companies survive long enough to fulfill their promise of treating genetic disorders? As the patent feud wages on, lives and fortunes hang in the balance.
If genetic modifications ever emerge as the medical miracle they're supposed to, there will be no stopping the use of the technology. All you need is for a country to refuse to enforce or recognize the patents, and presto -- the world's foremost medical tourism destination. I sort of despise the idea of patenting features of nature, so perhaps a bit of schadenfreude there.
I have no doubt the information will be spread, too. If Snowden can be widely hailed as a hero for leaking the NSA's rampant cybercrime, just imagine the pats on the back for the guy who leaks the key to cancer. (Yeah, yeah, along with threats of jail time, so he'll have to light out for Cambodia or whatever.)